Both in Pharmaceuticals
Merck & Co. vs Regeneron Pharmaceuticals
Over the past year MRK returned +81.3% and REGN returned +44.5%; their daily moves had a correlation of 0.39.
MRK +81.3% REGN +44.5%Growth of $1, one year, split-adjusted
| Metric | MRK | REGN |
|---|---|---|
| Price | $149.52 | $927.89 |
| Market cap | $368.89B | $95.99B |
| Today | +2.18% | +13.33% |
| 1 month | +4.0% | +26.3% |
| 6 months | +33.3% | +32.3% |
| Year to date | +42.0% | +20.2% |
| 1 year | +72.7% | +42.1% |
| Revenue growth (YoY) | +5.1% | +36.3% |
| Gross margin | 73.5% | 88.8% |
| Net margin | −8.0% | 38.1% |
| P/E (TTM) | 116.3× | 19.9× |
| Price / sales | 5.5× | 5.7× |
| Net cash | -$46.77B | $6.59B |
| Dividend yield | 2.27% | 0.41% |
| Volatility (60d) | 36.0% | 37.0% |
| Short % of float | 1.1% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).